Cosmo Direct Supply spotlights menopause skin research and Sculptra protocols for clinics

Cosmo Direct Supply is highlighting new Galderma research on menopause-related skin changes and how sequencing hydration before collagen stimulation may improve results. The company says the findings give clinics a clearer way to explain symptoms and build treatment plans for menopausal patients.

Why it matters: - Galderma’s new data gives clinics a more specific way to discuss menopause-related skin changes with patients who may think the issue is only aging. - The findings support multi-step treatment plans that start with hydration and then move to collagen stimulation. - Cosmo Direct Supply is positioning its product mix around that sequencing strategy for licensed medical professionals.

What happened: - Cosmo Direct Supply said it is responding to new Galderma research on menopause-related skin changes. - The research was published ahead of World Menopause Day on 18 October. - Galderma’s global survey included 5,090 women in the USA, UK, Brazil and China. - 56% of respondents first blamed menopause-related skin changes on aging. - 29% recognized menopause as the cause. - One in two women said they were unaware that hormonal changes during perimenopause and menopause can affect the skin.

The details: - Galderma also reported results from an eight-month investigator-initiated trial led by Dr. Andreas Nikolis and supported by Galderma. - The trial treated the face and décolletage of menopausal women. - Patients received Restylane Skinboosters and Sculptra in two different orders. - The group treated with Restylane Skinboosters first, followed by Sculptra, showed an earlier visible response. - Facial dermal thickness increased by 27.3% in the Skinboosters-first group, compared with 15.7% in the Sculptra-first group. - Across both groups, 98% of patients reported natural-looking results. - 96% said they would recommend the treatment. - 92% said they would undergo it again. - Cosmo Direct Supply offers Sculptra as a collagen-stimulating injectable for progressive improvement in skin quality and structure. - Cosmo Direct Supply also offers Restylane Skinboosters Vital Lidocaine and a lighter version to improve hydration and add the comfort of integrated lidocaine. - The products are available to licensed medical professionals at wholesale pricing, with volume-based discounts and fast shipping to clinics across the USA and internationally. - The company says its catalog is sourced as genuine, CE-certified product.

Between the lines: - The research points to a clinic conversation that is still new for many practitioners: how to explain menopause-driven skin changes in plain language. - Daniel Pashai, CEO at Cosmo Direct Supply, said menopausal skin is a segment many clinics are only starting to build protocols for. - Pashai said the research gives practitioners a clear starting point and a framework for explaining what patients are seeing in the mirror. - The sequencing result also reinforces a broader move toward layered protocols rather than single-product treatment plans.

What's next: - Cosmo Direct Supply said it will continue to follow new clinical research on menopause-related skin care. - The company said it will review its catalog as practitioner needs develop. - Clinics looking at menopausal skin protocols are likely to use the new data to shape patient education and treatment sequencing.

The bottom line: - The new research gives aesthetic clinics both a patient-education angle and a treatment roadmap for menopause-related skin changes.